Cargando…
The α9α10 Nicotinic Acetylcholine Receptor Antagonist αO-Conotoxin GeXIVA[1,2] Alleviates and Reverses Chemotherapy-Induced Neuropathic Pain
Oxaliplatin is a third-generation platinum drug and is widely used as a first-line therapy for the treatment of colorectal cancer (CRC). However, a large number of patients receiving oxaliplatin develop dose-limiting painful neuropathy. Here, we report that αO-conotoxin GeXIVA[1,2], a highly potent...
Autores principales: | Wang, Huanbai, Li, Xiaodan, Zhangsun, Dongting, Yu, Gang, Su, Ruibin, Luo, Sulan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562493/ https://www.ncbi.nlm.nih.gov/pubmed/31060282 http://dx.doi.org/10.3390/md17050265 |
Ejemplares similares
-
αO-Conotoxin GeXIVA Inhibits the Growth of Breast Cancer Cells via Interaction with α9 Nicotine Acetylcholine Receptors
por: Sun, Zhihua, et al.
Publicado: (2020) -
Differential Expression of Nicotine Acetylcholine Receptors Associates with Human Breast Cancer and Mediates Antitumor Activity of αO-Conotoxin GeXIVA
por: Sun, Zhihua, et al.
Publicado: (2020) -
Novel αO-conotoxin GeXIVA[1,2] Nonaddictive Analgesic with Pharmacokinetic Modelling-Based Mechanistic Assessment
por: Zhu, Xiaoyu, et al.
Publicado: (2022) -
Lyophilization Serves as an Effective Strategy for Drug Development of the α9α10 Nicotinic Acetylcholine Receptor Antagonist α-Conotoxin GeXIVA[1,2]
por: Li, Zhiguo, et al.
Publicado: (2021) -
Identification of Crucial Residues in α-Conotoxin EI Inhibiting Muscle Nicotinic Acetylcholine Receptor
por: Ning, Jiong, et al.
Publicado: (2019)